Chronic Lymphocytic Leucemia
4 clinical trials · Condition
◉ Watch Chronic Lymphocytic Leucemia
| Record | Firm | Date |
|---|---|---|
| Sequential Regimen of Bendamustine-Debulking Followed by CAL-101 and GA101-Induction and -Maintenance in CLL (CLL2-BCG) (NCT02445131) | German CLL Study Group | 2015-05-28 |
| Sequential Regimen of Bendamustine-Debulking Followed by ABT-199 and GA101-Induction and -Maintenance in CLL (CLL2-BAG) (NCT02401503) | German CLL Study Group | 2015-05-06 |
| Sequential Regimen of Bendamustin [B] Followed by GA101 and Ibrutinib [I] in CLL Patients (NCT02345863) | German CLL Study Group | 2015-01-16 |
| CLLR3: Bendamustine + GA101 (BG) in Relapsed or Refractory CLL Followed by GA101 Maintenance for Responding Patients (NCT02320383) | Munich Municipal Hospital | 2014-11-01 |
Track Chronic Lymphocytic Leucemia automatically
Every clearance here is in the API, with alerts when new ones post.